Joint Formulary & PAD

Formulary Search

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Search

A-Z of Drugs : A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

A-Z of Drugs

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Search Results : Urticaria (Fexofenadine hydrochloride - Urticaria)

Records returned : 8 (on 20 Oct 2025 at 10:20:09). Return to search results for ' Urticaria '.

Show Icon and Status Keys

Drug
Indication
Status
Restrictions/Comments
Formulary Status
Links
Indication :
Status :
Green (see narrative)
Formulations :
  • Tablets
Restrictions / Comments:

Important

180mg strength as 2nd line option after loratadine & cetirizine; both of which can be increased up to four times the standard licensed dose (off-label use) - see NICE CKS.


Advise patient that these products can be purchased over the counter for short-courses required for acute urticaria

 
Links :
SPC
Indication :
Status :
Green
Formulations :
  • Oral solution
  • Tablets
Restrictions / Comments:

Important
Preferred

Advise patient that these products can be purchased over the counter for short-courses required for acute urticaria

 
Links :
Indication :
Status :
Green
Formulations :
  • Oral solution
  • Tablets
Restrictions / Comments:

Important
Preferred

Advise patient that these products can be purchased over the counter for short-courses required for acute urticaria

 
Links :
SPC
Indication :
Status :
Green
Formulations :
  • Tablets
Restrictions / Comments:

 
Links :
SPC
Indication :
Status :
Non Formulary
Formulations :
  • Enteric coated tablets
Restrictions / Comments:

 
Links :
NFD1
SPC
Indication :
Status :
Green (see narrative)
Formulations :
  • Oral solution
  • Tablets
Restrictions / Comments:

Important

To consider if itch is interfering with sleep.

 
Links :
SPC
Indication :
Status :
Green (see narrative)
Formulations :
  • Chewable tablets
  • Sachets (granules)
  • Tablets
Restrictions / Comments:

Important

Off-label use.

For use if there is an inadequate response to increased dose antihistamine treatment.

https://www.gov.uk/drug-safety-update/montelukast-singulair-reminder-of-the-risk-of-neuropsychiatric-reactions

 
Links :
SPC
Indication :
Status :
Red
Formulations :
  • Injection
Restrictions / Comments:

Important

Restricted to dermatology, immunology or allergy specialists.

 
Links :